Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD)
Also known as: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) / Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders / Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease / Myelin oligodendrocyte glycoprotein antibody-associated disease (disorder) / Anti-myelin oligodendrocyte glycoprotein antibody associated encephalomyelitis / Anti-MOG disease
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB14919 | Rozanolixizumab | 3 | Recruiting | 1 |
| DB15762 | Satralizumab | 3 | Recruiting | 1 |